Cefuroxime Sodium/Sulbactam sodium

头孢呋辛钠/舒巴坦钠

Report date: 2026/05/26 20:00:28

Base Information

Drug NameCefuroxime Sodium/Sulbactam sodium
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsCystitisPyelonephritisMeningitis +[26] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Cefuroxime SodiumSulbactam sodium
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPending
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Hongtaiyang Pharmaceutical Co Ltd
Inactive CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Active IndicationsCystitisPyelonephritisMeningitis +[24] 
Inactive IndicationsBacterial InfectionsInfections

Other Information

ATC CodeN/A
Related LinksN/A